Editors:
Part of the book series: Current Topics in Microbiology and Immunology (CT MICROBIOLOGY, volume 279)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (20 chapters)
-
Front Matter
About this book
TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the antimycotic, rapamycin. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anbolic and catabolic responses. The editors have gathered the leading figures in the field of TOR and its role in cellular homeostasis and human diseases.
Editors and Affiliations
-
Friedrich-Miescher-Institute, Basel, Switzerland
George Thomas
-
Whitehead Institute, Cambridge, USA
David M. Sabatini
-
Biozentrum, University of Basel, Basel, Switzerland
Michael N. Hall
Bibliographic Information
Book Title: TOR
Book Subtitle: Target of Rapamycin
Editors: George Thomas, David M. Sabatini, Michael N. Hall
Series Title: Current Topics in Microbiology and Immunology
DOI: https://doi.org/10.1007/978-3-642-18930-2
Publisher: Springer Berlin, Heidelberg
-
eBook Packages: Springer Book Archive
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE, part of Springer Nature 2004
Hardcover ISBN: 978-3-540-00534-6Published: 25 August 2003
Softcover ISBN: 978-3-642-62360-8Published: 21 October 2012
eBook ISBN: 978-3-642-18930-2Published: 06 December 2012
Series ISSN: 0070-217X
Series E-ISSN: 2196-9965
Edition Number: 1
Number of Pages: X, 364
Topics: Medical Microbiology